Safety and Efficacy of the ZoMaxxâ„¢ Drug-Eluting Stent System in Coronary Arteries
Trial ID or NCT#
NCT00140101
Status
NOT RECRUITING
Purpose
The purpose of this study is to demonstrate the safety and efficacy of the ZoMaxx drug-eluting stent in patients with blockage of native coronary arteries. The study is designed to demonstrate non-inferiority to the TAXUS Express2 Paclitaxel-Eluting Stent that has proven superior to bare metal stents and is a recognized standard of care.
Official Title
A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System as Compared to the TAXUSâ„¢ Express2â„¢ Paclitaxel-Eluting Stent in de Novo Coronary Artery Lesions
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Exclusion Criteria:
Investigator(s)
View on